Leerink Swann restated their outperform rating on shares of Intuitive Surgical (NASDAQ:ISRG) in a research report report published on Thursday morning, Marketbeat Ratings reports. The brokerage currently has a $475.00 price target on the medical equipment provider’s stock, up from their prior price target of $390.00.

Several other research firms also recently issued reports on ISRG. Wedbush reiterated an outperform rating and set a $353.33 price target on shares of Intuitive Surgical in a research note on Monday, September 25th. Barclays reiterated an overweight rating on shares of Intuitive Surgical in a research note on Friday, October 20th. BidaskClub downgraded Intuitive Surgical from a strong-buy rating to a buy rating in a research note on Tuesday, December 12th. Zacks Investment Research upgraded Intuitive Surgical from a hold rating to a strong-buy rating and set a $437.00 price target for the company in a research note on Tuesday, December 12th. Finally, Goldman Sachs Group reiterated a buy rating on shares of Intuitive Surgical in a research note on Saturday, November 18th. One research analyst has rated the stock with a sell rating, four have given a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Intuitive Surgical currently has a consensus rating of Buy and an average price target of $368.71.

Shares of Intuitive Surgical (NASDAQ:ISRG) traded up $1.16 during mid-day trading on Thursday, reaching $433.23. The company’s stock had a trading volume of 727,593 shares, compared to its average volume of 919,870. The firm has a market cap of $48,540.00, a price-to-earnings ratio of 55.97, a P/E/G ratio of 5.39 and a beta of 0.47. Intuitive Surgical has a 12 month low of $217.19 and a 12 month high of $436.57.

In other Intuitive Surgical news, CFO Marshall Mohr sold 6,000 shares of the firm’s stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $372.22, for a total value of $2,233,320.00. Following the completion of the sale, the chief financial officer now owns 12,316 shares in the company, valued at approximately $4,584,261.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Curet Myriam sold 262 shares of the firm’s stock in a transaction that occurred on Tuesday, October 24th. The stock was sold at an average price of $373.00, for a total value of $97,726.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 55,944 shares of company stock valued at $21,432,971. 2.20% of the stock is owned by corporate insiders.

Several hedge funds have recently made changes to their positions in the business. Edgewood Management LLC lifted its position in shares of Intuitive Surgical by 200.7% in the 3rd quarter. Edgewood Management LLC now owns 2,898,113 shares of the medical equipment provider’s stock worth $1,010,359,000 after acquiring an additional 1,934,382 shares during the period. FMR LLC lifted its position in shares of Intuitive Surgical by 19.6% in the 2nd quarter. FMR LLC now owns 2,724,964 shares of the medical equipment provider’s stock worth $2,548,849,000 after acquiring an additional 447,397 shares during the period. Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 0.8% in the 2nd quarter. Vanguard Group Inc. now owns 2,524,027 shares of the medical equipment provider’s stock worth $2,360,900,000 after acquiring an additional 20,210 shares during the period. Koch Industries Inc. lifted its position in shares of Intuitive Surgical by 202,917.0% in the 2nd quarter. Koch Industries Inc. now owns 1,388,636 shares of the medical equipment provider’s stock worth $1,387,000 after acquiring an additional 1,387,952 shares during the period. Finally, Janus Henderson Group PLC lifted its position in shares of Intuitive Surgical by 42.0% in the 3rd quarter. Janus Henderson Group PLC now owns 585,196 shares of the medical equipment provider’s stock worth $612,042,000 after acquiring an additional 173,026 shares during the period. Institutional investors own 32.82% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Intuitive Surgical (ISRG) Stock Rating Reaffirmed by Leerink Swann” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2018/01/21/intuitive-surgical-isrg-stock-rating-reaffirmed-by-leerink-swann.html.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.